Diabetologia

Papers
(The H4-Index of Diabetologia is 54. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Branding foods as ‘healthy’ or ‘unhealthy’ based on marginal data calls findings into question. Reply to Kanter M [letter]675
Up Front405
Using genetics to assess the association of commonly used antihypertensive drugs with diabetes, glycaemic traits and lipids: a trans-ancestry Mendelian randomisation study202
In Memoriam Werner Waldhäusl, 27 September 1937–22 May 2025176
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities171
Targeted serum proteomics of longitudinal samples from newly diagnosed youth with type 1 diabetes distinguishes markers of disease and C-peptide trajectory150
The SWI/SNF chromatin remodelling complex regulates pancreatic endocrine cell expansion and differentiation in mice in vivo127
Considerations for more actionable consensus guidance for monitoring individuals with islet autoantibody‑positive pre‑stage 3 type 1 diabetes126
Critical comments regarding the assessment of quality of life and the clinical impact of the POWER2DM intervention. Reply to Pouwer F, Deschênes SS [letter]118
Chronic kidney disease in type 1 diabetes: translation of novel type 2 diabetes therapeutics to individuals with type 1 diabetes111
Birthweight, BMI in adulthood and latent autoimmune diabetes in adults: a Mendelian randomisation study110
Determination of autoantibodies in type 2 diabetes: one simple way to improve classification108
TBC1D30 regulates proinsulin and insulin secretion and is the target of a genomic association signal for proinsulin94
Differences in biopsy-proven diabetic kidney disease in individuals from Polynesia vs mainland France: a retrospective cohort study90
60th EASD Annual Meeting of the European Association for the Study of Diabetes89
Methodological considerations for interpreting long-term statin use and diabetes incidence88
Precision medicine in type 2 diabetes: targeting SGLT2 inhibitor treatment for kidney protection87
Paediatric diabetes subtypes in a consanguineous population: a single-centre cohort study from Kurdistan, Iraq86
Islet autoimmunity and progression to type 1 diabetes in the Finnish DIPP study: comparison between genetically susceptible children with and without an affected first-degree relative86
Cardiovascular risk management among individuals with type 2 diabetes and severe mental illness: a cohort study85
The metabolomic signature of weight loss and remission in the Diabetes Remission Clinical Trial (DiRECT)81
Inter- and intra-physician variability in insulin injection adjustments compared with Bayesian algorithm recommendations in type 1 diabetes81
Impact of normoglycaemia and prediabetes definitions on the estimated benefits of regression from prediabetes to normoglycaemia for type 2 diabetes risk78
Ageing well with diabetes: the role of technology76
Comparative renal outcomes of matched cohorts of patients with type 2 diabetes receiving SGLT2 inhibitors or GLP-1 receptor agonists under routine care75
Advanced glycation end-products, cardiac function and heart failure in the general population: The Rotterdam Study74
Scientists and scientific journals should adhere to ethical standards for the use and reporting of data from Indigenous people74
Glucagon-like peptide-1 receptor agonists reverse nerve morphological abnormalities in diabetic peripheral neuropathy73
Sex-dependent intra-islet structural rearrangements affecting alpha-to-beta cell interactions lead to adaptive enhancements of Ca2+ dynamics in prediabetic beta cells72
Embracing complexity: making sense of diet, nutrition, obesity and type 2 diabetes68
58th EASD Annual Meeting of the European Association for the Study of Diabetes67
Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials67
Loneliness increases the risk of type 2 diabetes: a 20 year follow-up – results from the HUNT study67
Heterotypic macrophages/microglia differentially contribute to retinal ischaemia and neovascularisation66
A simple score-based strategy to improve equity of the UK biennial diabetic eye screening protocol among people deemed as low risk66
Pen-administered low-dose dasiglucagon vs usual care for prevention and treatment of non-severe hypoglycaemia in people with type 1 diabetes during free-living conditions: a Phase II, randomised, open65
eNAMPT is a novel therapeutic target for mitigation of coronary microvascular disease in type 2 diabetes65
Up Front65
Daniel Porte Jr, 13 August 1931–13 May 202365
Effects of progressive resistance training in individuals with type 2 diabetic polyneuropathy: a randomised assessor-blinded controlled trial65
Pinpointing precision medicine for diabetes mellitus63
Reassessing the evidence: prandial state dictates glycaemic responses to exercise in individuals with type 1 diabetes to a greater extent than intensity62
Adverse pregnancy outcomes in women with type 1 diabetes are associated with multiple alterations in the vaginal microbiome62
Evaluating the role of alpha cell dysregulation in the progression to type 2 diabetes using mathematical simulations61
Racial/ethnic and socioeconomic disparities in achievement of treatment goals within a clinical trial: a secondary analysis of the ACCORD trial60
GLP-1 receptor agonists in lean diabetes in racial and ethnic minority groups: closing the treatment gap59
Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes58
Targeted proteomics identifies potential biomarkers of dysglycaemia, beta cell function and insulin sensitivity in Black African men and women58
Cholesterol crystal formation is a unifying pathogenic mechanism in the development of diabetic retinopathy58
Projecting the incidence and costs of major cardiovascular and kidney complications of type 2 diabetes with widespread SGLT2i and GLP-1 RA use: a cost-effectiveness analysis58
Mortality risk for kidney transplant candidates with diabetes: a population cohort study56
Loss of function of renal Glut2 reverses hyperglycaemia and normalises body weight in mouse models of diabetes and obesity55
Heterogeneity in response to GLP-1 receptor agonists in type 2 diabetes in real-world clinical practice: insights from the DPV register – an IMI-SOPHIA study55
Liver, visceral and subcutaneous fat in men and women of South Asian and white European descent: a systematic review and meta-analysis of new and published data55
Once-weekly IcoSema versus once-weekly semaglutide in adults with type 2 diabetes: the COMBINE 2 randomised clinical trial54
0.04411792755127